Imvax has secured $29m in a financing round from current investors, aimed at advancing the Phase IIb trial of its autologous ...
Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback